K193525

Substantially Equivalent

Yumizen C1200 Immunoglobulin A, Yumizen C1200 Immunoglobulin G, Yumizen C1200 Immunoglobulin M

Applicant: HORIBA ABX SAS
Product code: CZP
Advisory panel: Immunology
Date received: 2019-12-19
Decision date: 2020-06-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Montpellier Cedex 4, FR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.